Related Experiment Video
Updated: Aug 6, 2026

Fluorescence Assays for the Study of Mycobacterium tuberculosis Interaction with the Immune Receptor SLAMF1
Published on: February 28, 2025
Pathogenesis of Tuberculosis: Interplay Between Host Antituberculosis Immunity and Immune Evasion Strategies of
Xiaojuan Zhang1, Ying Liu1, Yilin Hou1
1Key Laboratory of Blood-stasis-toxin Syndrome of Zhejiang Province School of Basic Medical Science Zhejiang Chinese Medical University Hangzhou Zhejiang China.
Abstract:
Tuberculosis remains one of the leading causes of death from a single infectious pathogen worldwide, despite the availability of antituberculosis chemotherapy and Bacillus Calmette-Guérin vaccination. Tuberculosis pathogenesis is driven by a dynamic and prolonged interplay between host protective immunity and the immune evasion strategies of Mycobacterium tuberculosis (M. tuberculosis). During infection, bidirectional host-M. tuberculosis interactions, together with immunometabolic and epigenetic reprogramming, shape granuloma formation and organization, fibrotic encapsulation, liquefactive necrosis, and ultimately determine disease progression and transmission. However, a systematic framework linking host protective immunity, M. tuberculosis immune evasion, and granuloma evolution across distinct stages of infection remains incomplete. In this review, we summarize the host-M. tuberculosis interactions that shape early innate immune recruitment, adaptive immune activation, granuloma formation and remodeling, persistent infection, granuloma breakdown, and progression to active tuberculosis. We further integrate emerging concepts of metabolic reprogramming, epigenetic reprogramming, trained immunity, tissue-resident immunity, and myeloid-derived immunosuppressive networks. Finally, we discuss how these mechanistic insights may inform the design of next-generation tuberculosis vaccines and adjunctive therapies. This review establishes a comprehensive conceptual framework for understanding tuberculosis immunopathogenesis and provides guidance for the development of antituberculosis vaccines and therapeutic strategies.
Related Concept Videos
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Tuberculosis
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
